Charlie Alovisetti is a partner at Vicente LLP and chair of the firm’s Corporate Department. Recognized by Chambers & Partners as one of the top cannabis lawyers in the United States, he is also co-author of The Business of Cannabis: Understanding Law, Finance, and Governance in America’s Newest Industry.

Charlie focuses his practice on advising investors, companies, and other law firms on the nuances of executing corporate transactions involving licensed and ancillary cannabis companies. With experience working on licensed transactions in all major cannabis markets in the United States, Charlie has a deep understanding of the state and local issues that commonly arise in stock and asset acquisitions and issues involved in management companies and other alternative structures. This experience and knowledge make him a vital resource for clients. He also has experience counseling portfolio and emerging growth companies with respect to general corporate and commercial matters and compensation arrangements.

In addition to his corporate practice, Charlie provides specialized cannabis counsel to non-cannabis companies seeking to evaluate the risks of entering the cannabis space and structure their investments to reduce risks.

Prior to joining Vicente LLP, Charlie worked as an associate in the New York offices of Latham & Watkins and Goodwin, where he represented public companies and private equity sponsors and their portfolio companies in a range of corporate transactions.

Charlie holds a Bachelor of Arts, with honors, from McGill University and a law degree from Columbia Law School, where he was a Harlan Fiske Stone Scholar. He is admitted to practice in Colorado, Massachusetts, and New York.

Recognized as a thought leader and experienced practitioner in the areas of cannabis M&A and financings, Charlie is an author and frequent speaker at events. In addition to his recognition by Chambers, he was named one of Boston’s Top Lawyers by Boston magazine in 2021 and 2022. During his time practicing in Colorado, Charlie participated in a number of working groups related to the cannabis industry, including the group focused on HB19-1090—the bill that permitted public company investment.